SLC6A3 and Parkinson disease: Furthermore, administration of Tx14(A) consistently led to increased expression levels of GPR37L1, TH, DAT and synaptic markers in both SNpc and STR (Fig. 6H-K), suggesting that Tx14(A) may not only improve motor function but also promote dopaminergic neuron survival and function in PD mouse.